Amy Paller, MD, Discusses Long-Term Safety and Efficacy of Ixekizumab in Kids

Article

Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.

Related Videos
Related Content

Severe Psoriasis Associated With Higher Risk of Heart Disease

September 26th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color

September 20th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Treating All Skin Tones

September 19th 2023

GRAPPA Continues Efforts to Advance Care for Patients With Plaque Psoriasis

September 15th 2023

Severe Psoriasis Associated With Higher Risk of Heart Disease

September 26th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color

September 20th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Treating All Skin Tones

September 19th 2023

GRAPPA Continues Efforts to Advance Care for Patients With Plaque Psoriasis

September 15th 2023

Severe Psoriasis Associated With Higher Risk of Heart Disease

September 26th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color

September 20th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Treating All Skin Tones

September 19th 2023

GRAPPA Continues Efforts to Advance Care for Patients With Plaque Psoriasis

September 15th 2023
© 2023 MJH Life Sciences

All rights reserved.